• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测方法和干扰因素对地高辛浓度解读的影响。

Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.

作者信息

Fitzsimmons W E

出版信息

Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):538-42. doi: 10.1177/106002808602000703.

DOI:10.1177/106002808602000703
PMID:3755675
Abstract

The interpretation of serum digoxin concentrations is an area where pharmacists can have substantial clinical input. Important in this interpretation is the knowledge of various factors that may interfere with the reported concentration. These include drugs, metabolites of digoxin, protein concentration, and endogenous digoxin-like substances. The patients for whom these interferences are most significant include neonates, patients with renal failure and liver disease, and pregnant women. Pharmacist knowledge of these interferences can have an important impact on the quality of patient care.

摘要

血清地高辛浓度的解读是一个药剂师可提供大量临床意见的领域。解读时,了解各种可能干扰报告浓度的因素很重要。这些因素包括药物、地高辛代谢物、蛋白质浓度和内源性地高辛样物质。这些干扰最为显著的患者包括新生儿、肾衰竭和肝病患者以及孕妇。药剂师对这些干扰因素的了解会对患者护理质量产生重要影响。

相似文献

1
Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.检测方法和干扰因素对地高辛浓度解读的影响。
Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):538-42. doi: 10.1177/106002808602000703.
2
A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Ann Clin Lab Sci. 1989 May-Jun;19(3):168-74.
3
Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.测量低体重儿血清中的内源性洋地黄样物质和外源性地高辛。
Am J Hosp Pharm. 1985 Sep;42(9):1977-9.
4
Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.在洋地黄毒苷中毒病例中,尽量减少来自洋地黄毒苷样免疫反应性物质(DLIS)的分析干扰。
J Forensic Sci. 1987 May;32(3):650-7.
5
Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.通过疏水硅胶萃取和酶免疫测定法从血清样本中去除内源性地高辛样免疫反应因子。
Clin Chem. 1987 Mar;33(3):401-4.
6
Endogenous digoxin-like substances.
J Pediatr. 1986 Nov;109(5):910-1.
7
Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.地高辛放射免疫分析无法检测新生儿、婴儿或肾衰竭患者血清中的地高辛样物质。
Clin Chem. 1987 Mar;33(3):420.
8
Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.洋地黄样免疫反应物质对“达可心”地高辛检测法的影响。
Clin Chem. 1987 Sep;33(9):1697.
9
Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.在ADVIA 1650分析仪上的新型胶乳比浊法地高辛免疫测定中,血清地高辛测量中内源性地高辛样免疫反应因子的干扰被降至最低。
Ther Drug Monit. 2004 Feb;26(1):85-9. doi: 10.1097/00007691-200402000-00016.
10
Endogenous digoxin-immunoactive factor in human subjects.人体中的内源性地高辛免疫活性因子。
Fed Proc. 1985 Sep;44(12):2800-5.

引用本文的文献

1
Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?强心苷的血清浓度监测。它对调整给药方案有多大帮助?
Clin Pharmacokinet. 1991 Mar;20(3):175-93. doi: 10.2165/00003088-199120030-00001.